Skip to main content

Yu Shyr Archives

Vanderbilt Data Science Institute launched

Aug. 13, 2018—Vanderbilt has established the Data Science Institute to advance foundational research and data science skills across campus and to leverage the university’s collaborative culture.

Read more


Working group recommends new data sciences institute, faculty and educational programs

May. 14, 2018—A data science institute, new faculty and technical staff, and expanded educational offerings are the key investments recommended by the Data Science Visions Working Group.

Read more


Lewis’ Discovery Lecture

Jan. 18, 2018—Clinical trials expert Roger Lewis, MD, PhD, right, poses with Vanderbilt’s Yu Shyr, MD, following his recent Discovery Lecture. Lewis is chair of Emergency Medicine at Harbor-UCLA Medical Center in Los Angeles.

Read more


New working group launches for big data and data science initiatives

Aug. 17, 2017—Provost and Vice Chancellor for Academic Affairs Susan R. Wente has named 20 faculty members to a new working group that will analyze the directions for new big data and data science initiatives.

Read more


Shyr named chair of Department of Biostatistics

Jul. 20, 2017—Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1.

Read more


Nine Vanderbilt faculty members elected AAAS fellows

Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Read more


VICC investigators in spotlight at AACR conference

May. 19, 2016—A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.

Read more


IOM study calls for better evidence for biomarker tests

Mar. 10, 2016—Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.

Read more


Moses, Shyr named to Institute of Medicine cancer therapies panel

Mar. 5, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.

Read more


Event celebrates 12 Vanderbilt endowed chair holders

Aug. 30, 2013—Twelve Vanderbilt University faculty members named to endowed chairs were lauded for their extraordinary academic achievements during an Aug. 28 celebration.

Read more


Genomic research gains ad-“vantage” with new resources

Nov. 1, 2012—Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

Read more


Study tracks how gene may promote lung cancer tumors

Aug. 9, 2012—Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

Read more


Upcoming Events

MORE EVENTS »